Cogstate Limited (ASX:CGS)

Market Cap	227.10M
Revenue (ttm)	76.27M
Net Income (ttm)	11.87M
Shares Out	169.48M
EPS (ttm)	0.07
PE Ratio	19.52
Forward PE	20.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,895
Average Volume	269,420
Open	1.340
Previous Close	1.320
Day's Range	1.315 - 1.345
52-Week Range	0.795 - 1.440
Beta	-0.19
RSI	50.42
Earnings Date	Feb 20, 2025

About Cogstate

Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional ...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1999
• Employees: 160
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CGS

Financial Performance

In 2024, Cogstate's revenue was $43.43 million, an increase of 7.36% compared to the previous year's $40.45 million. Earnings were $5.45 million, an increase of 52.75%.

Financial numbers in USD